BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31414134)

  • 1. Regression of Recurrent Spinal Cord High-Grade Glioma After Convection-Enhanced Delivery of Nimustine Hydrochloride: Case Reports and Literature Review.
    Endo T; Inoue T; Sugiyama S; Saito R; Tominaga T
    Oper Neurosurg (Hagerstown); 2020 Apr; 18(4):451-459. PubMed ID: 31414134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convection-enhanced delivery of a hydrophilic nitrosourea ameliorates deficits and suppresses tumor growth in experimental spinal cord glioma models.
    Ogita S; Endo T; Sugiyama S; Saito R; Inoue T; Sumiyoshi A; Nonaka H; Kawashima R; Sonoda Y; Tominaga T
    Acta Neurochir (Wien); 2017 May; 159(5):939-946. PubMed ID: 28247160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride.
    Saito R; Sonoda Y; Kumabe T; Nagamatsu K; Watanabe M; Tominaga T
    J Neurosurg Pediatr; 2011 May; 7(5):522-6. PubMed ID: 21529193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Delivery of Nimustine Hydrochloride against Brain Tumors: Basic Characterization Study.
    Shao X; Saito R; Sato A; Okuno S; Saigusa D; Saito R; Uruno A; Osada Y; Kanamori M; Tominaga T
    Tohoku J Exp Med; 2023 Nov; 261(3):187-194. PubMed ID: 37635063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and feasibility of convection-enhanced delivery of nimustine hydrochloride co-infused with free gadolinium for real-time monitoring in the primate brain.
    Sugiyama S; Saito R; Nakamura T; Yamashita Y; Yokosawa M; Sonoda Y; Kumabe T; Watanabe M; Tominaga T
    Neurol Res; 2012 Jul; 34(6):581-7. PubMed ID: 22709625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma.
    Saito R; Kanamori M; Sonoda Y; Yamashita Y; Nagamatsu K; Murata T; Mugikura S; Kumabe T; Wembacher-Schröder E; Thomson R; Tominaga T
    Neurooncol Adv; 2020; 2(1):vdaa033. PubMed ID: 32642691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
    Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
    J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
    Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
    Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.
    Zhang R; Saito R; Mano Y; Kanamori M; Sonoda Y; Kumabe T; Tominaga T
    J Neurosci Methods; 2014 Jan; 222():131-7. PubMed ID: 24269253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
    Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
    J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local drug delivery in recurrent malignant gliomas.
    Boiardi A; Eoli M; Salmaggi A; Lamperti E; Botturi A; Solari A; Di Meco F; Broggi G; Silvani A
    Neurol Sci; 2005 May; 26 Suppl 1():S37-9. PubMed ID: 15883691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma.
    Wakabayashi T; Yoshida J; Mizuno M; Kajita Y
    Brain Tumor Pathol; 2001; 18(1):23-8. PubMed ID: 11517970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.
    Lidar Z; Mardor Y; Jonas T; Pfeffer R; Faibel M; Nass D; Hadani M; Ram Z
    J Neurosurg; 2004 Mar; 100(3):472-9. PubMed ID: 15035283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
    Wang JL; Barth RF; Cavaliere R; Puduvalli VK; Giglio P; Lonser RR; Elder JB
    PLoS One; 2020; 15(12):e0244383. PubMed ID: 33373402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.
    Spinazzi EF; Argenziano MG; Upadhyayula PS; Banu MA; Neira JA; Higgins DMO; Wu PB; Pereira B; Mahajan A; Humala N; Al-Dalahmah O; Zhao W; Save AV; Gill BJA; Boyett DM; Marie T; Furnari JL; Sudhakar TD; Stopka SA; Regan MS; Catania V; Good L; Zacharoulis S; Behl M; Petridis P; Jambawalikar S; Mintz A; Lignelli A; Agar NYR; Sims PA; Welch MR; Lassman AB; Iwamoto FM; D'Amico RS; Grinband J; Canoll P; Bruce JN
    Lancet Oncol; 2022 Nov; 23(11):1409-1418. PubMed ID: 36243020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.
    Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM
    J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
    Saito R; Tominaga T
    Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
    Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.
    Zhou Z; Singh R; Souweidane MM
    Curr Neuropharmacol; 2017; 15(1):116-128. PubMed ID: 27306036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.